Sarda Proteins Q2 Results FY27: Revenue Drops 81.16% to Rs 0.81 Cr, PAT Rs 0.14 Cr
- October 31, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Sarda Proteins Q2 Results FY27 were declared on 30 October 2026, and the standalone results show revenue of Rs 0.81 Cr, down 81.16% from Rs 4.3 Cr, a negative YoY growth figure. Net profit fell 65% to Rs 0.14 Cr from Rs 0.4 Cr. Operating Profit was Rs 0.19 Cr against Rs 0.3 Cr. These quarterly results cover the July to September 2026 quarter on a Standalone basis.
Sarda Proteins Ltd (FRESITA) Q2 Results FY27 announced on 30 October 2026, covering the company’s financial performance for the July to September quarter. Revenue was Rs 0.81 Cr and PAT was Rs 0.14 Cr, both lower than a year earlier. In this Sarda Proteins Q2 Results FY27 coverage, the results date and the Standalone results basis set the frame, and each comparison below is made against the same quarter of last year.
For readers tracking Sarda Proteins Q2 Results, this results analysis from Univest covers the financial highlights, business drivers, outlook and risks, and it begins with the Financial Highlights below.
Click Here – Get Free Investment Predictions
Sarda Proteins Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 0.81 Cr | Rs 4.3 Cr | -81.16% YoY |
| Operating Profit | Rs 0.19 Cr | Rs 0.3 Cr | -36.67% YoY |
| Net Profit (PAT) | Rs 0.14 Cr | Rs 0.4 Cr | -65% YoY |
Source: company filing for Sarda Proteins Q2 Results FY27, 30 October 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Sarda Proteins Q2 Results: What Stands Out
- Revenue: Rs 0.81 Cr against Rs 4.3 Cr a year earlier, a negative YoY growth figure of 81.16% on the top line.
- Net profit: Net profit fell 65% YoY to Rs 0.14 Cr from Rs 0.4 Cr in the same quarter last year.
- Operating Profit: Rs 0.19 Cr against Rs 0.3 Cr a year earlier, a decline of 36.67%, which is smaller than the fall in revenue.
- Net margin: Net profit margin improved to 17.3% from 9.3% in the comparison quarter, as net profit fell less steeply than revenue.
- Profit lines: Sarda Proteins Q2 Results FY27 show both profit lines falling by less than revenue, which the performance analysis below examines.
Sarda Proteins Q2 Results FY27: Performance Analysis
The numbers show a sharp drop in revenue with smaller declines in profit. Sarda Proteins reported standalone revenue of Rs 0.81 Cr, which is 81.16% lower YoY, while Operating Profit fell to Rs 0.19 Cr and net profit fell 65% to Rs 0.14 Cr. This results analysis starts with the top line.
Sarda Proteins Q2 Results FY27 show revenue moving from Rs 4.3 Cr to Rs 0.81 Cr. Operating Profit slipped from Rs 0.3 Cr to Rs 0.19 Cr, and net profit dropped from Rs 0.4 Cr to Rs 0.14 Cr. Because profit fell by less than revenue, the net profit margin rose to 17.3% from 9.3%.
Readers of Sarda Proteins Q2 Results will want to track whether later quarterly results show revenue recovering from Rs 0.81 Cr and whether the margin of 17.3% holds in later disclosures. The margin comparison sets the reference point, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Margin Improvement – The results analysis points to margin first: net profit margin improved to 17.3% from 9.3% in the comparison quarter. Sarda Proteins Q2 Results FY27 therefore show a higher share of each rupee of revenue reaching net profit, even though the absolute revenue and profit figures are lower.
Debt Position – The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY25. This annual figure indicates that borrowings were not a visible burden on the balance sheet in the last full year, which gives context to the quarterly results.
Margin Level – Net profit margin was 17.3% in the latest quarter, which is net profit of Rs 0.14 Cr on revenue of Rs 0.81 Cr. This level is the reference point readers compare with the 9.3% margin of the same quarter last year when reading standalone figures.
FY27 Outlook After Sarda Proteins Q2 Results
The FY27 view rests on the numbers already reported. Sarda Proteins Q2 Results FY27 combine lower revenue of Rs 0.81 Cr with net profit of Rs 0.14 Cr, and the full-year FY27 results will depend on what the coming quarters report and on disclosed sector conditions.
A results analysis for the rest of FY27 would compare revenue, the Rs 0.19 Cr Operating Profit and net profit with future quarters. The Univest Screener lets readers follow those comparisons as filings arrive, and those comparisons, rather than any forecast, decide how the full year reads, which brings the risks into view.
Key Risks to Watch After Sarda Proteins Q2 Results FY27
Revenue Decline
Revenue declined 81.2% year on year to Rs 0.81 Cr in the latest quarter. Sarda Proteins Q2 Results FY27 therefore show a much lower revenue base than a year earlier, and the YoY growth figure stays negative until later quarters report otherwise.
Net Profit Fall
Net profit fell 65.0% year on year to Rs 0.14 Cr. Operating Profit also moved lower, to Rs 0.19 Cr from Rs 0.3 Cr, so both profit lines sit below the levels of the same quarter last year.
Low Returns on Capital
Return on equity was low at 0.32% in FY25, and return on capital employed was modest at 0.86%. These annual figures indicate limited returns on equity and capital in the last full year, so quarterly profit is read together with them.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Sarda Proteins Q2 Results FY27 show standalone revenue of Rs 0.81 Cr, Operating Profit of Rs 0.19 Cr and net profit of Rs 0.14 Cr. These quarterly results show lower revenue and profit YoY alongside a higher net profit margin, and readers of Sarda Proteins Q2 Results should compare the filing with standalone results of later quarters and consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Sarda Proteins Q2 Results FY27
What are Sarda Proteins Q2 Results FY27?
Ans. Sarda Proteins Q2 Results FY27 are the standalone results for the July to September 2026 quarter, with revenue of Rs 0.81 Cr and net profit of Rs 0.14 Cr. This is covered in the Quick Answer section.
What is the results date for Sarda Proteins Q2 Results FY27?
Ans. The results date for Sarda Proteins Q2 Results FY27 is 30 October 2026, when the company declared its standalone results, so the introduction of this article sets out the announcement and the quarter covered.
What revenue was reported in Sarda Proteins Q2 Results FY27?
Ans. Sarda Proteins Q2 Results FY27 report revenue of Rs 0.81 Cr, compared with Rs 4.3 Cr a year earlier, which is why the Financial Highlights table shows a much lower top line for the quarter.
What net profit was reported in Sarda Proteins Q2 Results FY27?
Ans. Net profit in Sarda Proteins Q2 Results FY27 was Rs 0.14 Cr, compared with Rs 0.4 Cr in the same quarter last year, a fall of 65%, as the performance analysis explains.
How much YoY growth did revenue show in Sarda Proteins Q2 Results FY27?
Ans. Revenue showed YoY growth of negative 81.16% in Sarda Proteins Q2 Results FY27, falling from Rs 4.3 Cr to Rs 0.81 Cr, while the Key Takeaways section lists this alongside the other headline movements.
Did net profit rise or fall in Sarda Proteins Q2 Results?
Ans. Net profit fell in Sarda Proteins Q2 Results, dropping 65% to Rs 0.14 Cr from Rs 0.4 Cr, although the net profit margin rose, as discussed in the Performance Analysis section.
What was the Operating Profit in Sarda Proteins Q2 Results FY27?
Ans. Operating Profit in Sarda Proteins Q2 Results FY27 was Rs 0.19 Cr against Rs 0.3 Cr a year earlier, a decline of 36.67%, as noted in the Key Takeaways section for the quarter.
Are Sarda Proteins Q2 Results consolidated results or standalone results?
Ans. Sarda Proteins Q2 Results are standalone results, so the revenue, Operating Profit and net profit figures reflect the company on its own, which the Conclusion section also states for the July to September 2026 quarter.
What business factors shaped Sarda Proteins Q2 Results FY27?
Ans. A net profit margin of 17.3% against 9.3% and a debt-to-assets ratio of 0.00 in FY25 are the business factors behind Sarda Proteins Q2 Results FY27, as the Key Business Factors section details.
What are the key risks after Sarda Proteins Q2 Results FY27?
Ans. Key risks after Sarda Proteins Q2 Results FY27 are the 81.2% revenue decline, the 65.0% fall in net profit and return on equity of 0.32% in FY25, as set out under Key Risks to Watch.
What is the outlook after Sarda Proteins Q2 Results?
Ans. Full-year FY27 results after Sarda Proteins Q2 Results will depend on the quarters still to be reported and on disclosed conditions, while the Outlook section keeps to the numbers already reported.
Where can I find the complete Sarda Proteins Q2 Results FY27 data?
Ans. The complete Sarda Proteins Q2 Results FY27 data is in the Financial Highlights table above, while the Univest app and Screener carry the company’s stock page for further figures.
